Publication:

Rh sensitized pregnancy with high ICT titre wit favourable foetal outcome: a rare case

Leiomyosarcoma Rhesus (Rh) isoimmunization is the development of maternal IgG antibodies against fetal Rh Red Blood Cell (RBC) antigens. Transplacental passage of maternal Rh antibody (IgG anti-D) may result in Hemolytic Disease of the Newborn (HDN), a condition characterized by hemolysis, severe fetal anemia and generalized fetal edema (hydrops fetalis). The severity of Rh hemolytic disease may be assessed in the Immunized patient by several different means which include: past obstetric history, maternal antibody titer, ultrasonography, amniotic fluid bilirubin quantification, and percutaneous umbilical blood sampling. A past history of fetal demise, hydrops fetalis, intrauterine transfusion or neonatal exchange transfusion implies that the present pregnancy is or will be severely affected because Rh disease effects on the fetus generally recur or present progressively earlier or more severely with each successive Rh positive pregnancy. We present here a rare case of Rh sensitized pregnancy with high ICT titre who had normal fetal outcome.